Cron’s treatment.

Cron disease is an unexplained intestinal inflammation that can occur in any part of the gastrointestinal tract, but is good for the end of the intestine and the right half of the colon. It inflicts a series of pains on patients, including abdominal pain, diarrhoea and intestinal infarction, which seriously affect the quality of life. In the digestive medicine, there are a number of effective treatments for Cron disease. The drug treatment is the cornerstone of amino-water canyon acids, which are commonly used to treat mild and moderate Cronn disease. For example, nitrous sulfur, which is classified by bacteria in the intestinal tract as 5 – amino- and sulfamide, 5 – amino-sulphate inhibits the formation of prostate synthesis and inflammation media, thus reducing intestinal inflammation. Patients whose pathologies are limited to the colon have better treatments to mitigate symptoms such as diarrhoea, abdominal pain, and to improve intestinal mucous membranes. Sugar cortex hormones, when the patient’s condition is in a medium-to-heavy activity, becomes the key treatment. For example, Ponesson, it can rapidly reduce the inflammation response. For patients with acute symptoms such as fever, abdominal pain and diarrhoea, the use of sugar cortex hormones can control the condition in a short period of time. However, the long-term use of sugar cortex hormones has more adverse effects, such as osteoporosis, increased blood sugar, increased risk of infection, etc., which generally requires a gradual reduction to a stoppage after abating. Immunosuppressants are used for hormonal dependent or ineffective patients. Sulphurium and 6 – lymphoids are commonly used as immunosuppressants, which regulate the immune function of the organism by inhibiting the growth of lymphocytes and reducing inflammation damage to the intestinal tract. The use of immunosuppressants requires close monitoring of indicators such as blood routines and liver function, as adverse effects such as bone marrow inhibition and liver damage may occur. Biological agents are a new breakthrough in recent years in the treatment of Cron. Influencing is an anti-tumour necrosis – an anti-alpha monoclon, which combines the tumour necrosis with alpha, which prevents inflammation. For persons with moderate-level Crohn who have not been able to perform traditional treatments, especially those associated with fistula formation, biological agents can contribute to fistula healing, improve intestinal inflammation and damage and improve the quality of life of patients. Nutritional support for treatment is indispensable because people with Crohn are often associated with abdominal pain, diarrhoea, etc., and intestinal absorption is affected and prone to malnutrition. Nutritional support treatment is therefore an important link throughout the treatment process. For the less ill, diets can be adapted to provide high calorie, high protein, low fat and vitamin-rich slag diets. Intestine nutritional support may be required for patients with more serious conditions, narrow intestines or intestinal infarction, for example, through nasal feeding or gastrointestinal fistula. In some exceptional cases, extra-intestinal nutritional support is also required when the patient ‘ s intestinal function is severely impaired to withstand intestinal nutrition. The choice of endoscopy and surgical treatment is also applied in digestive medicine. For some patients with narrow intestinal tracts, intestinal infarction can be mitigated through endoscopy. If, however, the patient suffers from serious cortex, perforation, abdominal absema or if the internal medical treatment is ineffective, surgical intervention is required. However, surgical treatment is not a cure, and there is still a risk of relapse after surgery, so post-operative drug maintenance treatment remains essential. In general, the treatment of Crohn ‘ s disease in digestive medicine is an integrated process, requiring the selection of appropriate medications, nutritional support programmes, combined with endoscopy or surgery, if necessary, in order to control the condition, reduce relapse and improve the quality of life of the patient, depending on the patient ‘ s specific condition, the region of the disease and the level of activity of the disease. At the same time, the long-term follow-up and management of patients is also key to the success of treatment, which is adjusted in a timely manner through regular testing and evaluation.